Identification of a novel HLA-A*02 variant, HLA-A*02:586, in a Taiwanese bone marrow hematopoietic stem cell donor

HLA : Immune Response Genetics
K L YangP Y Lin

Abstract

One nucleotide substitution at residue 179 of the HLA-A*02:07:01 results in a new allele, HLA-A*02:586.

References

Apr 2, 2010·Tissue Antigens·S G E MarshJ Trowsdale

❮ Previous
Next ❯

Citations

Feb 2, 2016·Human Immunology·Steven G E Marsh, UNKNOWN WHO Nomenclature Committee for Factors of the HLA System
Feb 20, 2016·HLA : Immune Response Genetics·Steven G E Marsh, UNKNOWN WHO Nomenclature Committee for Factors of HLA System

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.